Latest Biotech News

Exact Sciences launched Cancerguard, a multi-cancer early detection test combining circulating tumor DNA and protein biomarkers, expanding screening capabilities. Quantum-Si introduced a V4...

Several key executive changes highlight strategic repositioning: Takeda named Rhonda Pacheco, a longtime Eli Lilly executive, to lead its US business unit amid Lilly reconsidering its UK incubator...

Major pharmaceutical companies Merck, AstraZeneca, and Eli Lilly have each halted or reconsidered significant investments in the United Kingdom's life sciences sector. Merck withdrew from a large...

New studies reveal crucial insights into cancer therapy and resistance mechanisms. One investigation utilizes cutting-edge single-cell and spatial omics to dissect breast cancer tumor...

The biopharmaceutical sector has seen a strong influx of capital this year, with record deal values and exciting public offerings. Dealmaking topped $185 billion through August 2025, marking the...

Partnerships and funding highlight AI's growing impact in biotechnology. Ultima Genomics and Sapio Sciences have partnered to integrate Sapio's AI-driven lab informatics with Ultima's low-cost...

New research advances understanding and treatment of neurodegenerative diseases. Studies reveal that familial Alzheimer’s mutations impair neurotrophic exosome secretion by brain immune cells,...

Innovations in sequencing technology are transforming genomics research. MGI launched the T7+ high-throughput sequencer capable of generating over 14Tb of data per day, enabling large-scale...

Cutting-edge therapeutic advances progress for diverse diseases. Iambic Therapeutics disclosed potent preclinical activity of IAM-1363, an irreversible HER2 inhibitor, in non-small cell lung...

The FDA is intensifying scrutiny of its processes and communications. Officials plan to present data suggesting links between Covid-19 vaccines and child deaths at an upcoming CDC advisory...

Precision oncology and diagnostics receive significant enhancements through multiomics technologies and liquid biopsy platforms. Personalis and Yale launched a clinical trial evaluating...

Exact Sciences has introduced Cancerguard, a multi-cancer early detection blood test designed to identify over 50 cancer types through circulating tumor DNA and tumor-associated protein...

Revolution Medicines announced plans to initiate a global, randomized Phase III trial for daraxonrasib, a multi-selective RAS inhibitor, as a first-line treatment for metastatic pancreatic ductal...

Avidity Biosciences shared positive Phase I/II results for del-zota, an antibody-oligonucleotide conjugate showing reversal of Duchenne muscular dystrophy progression after one year of continuous...

Several biotech firms and academic researchers report advancements integrating AI and CRISPR technologies. Goodpath secured $18 million to expand its chronic condition AI platform, while VedaBio...

Recent regulatory developments include Vinay Prasad’s reinstatement to additional leadership roles at the FDA’s CBER, reaffirming his influence in biologics evaluation. The FDA also issued draft...

Facing intense market competition and slowing growth, Novo Nordisk announced a plan to cut 9,000 jobs and recalled all staff to full-time, in-office work to enhance decision-making and commercial...

Sapio Sciences entered a strategic partnership with Ultima Genomics to integrate its AI-driven lab informatics platform with Ultima’s low-cost high-throughput sequencing technology. The...

Recent studies reveal novel molecular insights into Alzheimer’s disease. Research from Aarhus University identified that familial SORLA mutations impair exosome production, critical for neuronal...

Researchers at Rockefeller University utilized terabase-scale long-read sequencing directly from soil samples to bypass culturing limitations and assemble hundreds of complete bacterial genomes...